Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
01 / The disclosure
What the company shared
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
The evidence
Read the source excerpts
01Name of the Target Company (TC) JAY ARVIND BHANUSHALI Whether the acquirer belongs to Promoter/Promoter group Details of the acqusition/ disposal as follows Number % w.r.t.
Page 2
02After the acquisition/sale, holding of: a) Shares carrying voting rights JAY ARVIND BHANUSHALI 7,49,507 7.28 7.28 - - - c) VRs otherwise than by shares 0 0 0 d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition 0 0 0 e) Total (a+b+c+d) 7,49,507 7.28 7.28 Mode of acquisition / sale (e.g.
Page 3
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 3a01f2e6-b4bd-4067-81a3-f6d239c280f2
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 3 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- c8ff6d60da6e79af9fa995c30730d090df1c30b2a9f4276039d6f50965d863f5